Samuel Valable
18
Documents
Identifiants chercheurs
samuel-valable- ResearcherId : B-7578-2008
-
0000-0003-0355-0270
- IdRef : 085766127
- ResearcherId : http://www.researcherid.com/rid/B-7578-2008
Présentation
samuel valable,hypoxia
Publications
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 18
- 17
- 16
- 16
- 13
- 13
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 10
- 3
- 1
- 1
|
|
Ruthenium tris(2,2′-bipyridyl) complex encapsulated in nanosized faujasite zeolite as intracellular localization tracerJournal of Colloid and Interface Science, 2020, 581 (Part B), pp.919-927. ⟨10.1016/j.jcis.2020.08.117⟩
Article dans une revue
hal-02935419v1
|
|
|
Hadrontherapy Interactions in Molecular and Cellular BiologyInternational Journal of Molecular Sciences, 2020, 21 (1), pp.133. ⟨10.3390/ijms21010133⟩
Article dans une revue
hal-02429129v1
|
|
|
Angiopoietin-2 Combined with Radiochemotherapy Impedes Glioblastoma Recurrence by Acting in an Autocrine and Paracrine Manner: A Preclinical StudyCancers, 2020, 12 (12), pp.3585. ⟨10.3390/cancers12123585⟩
Article dans une revue
hal-03082539v1
|
Impact of tumor reoxygenation by nanoparticles on tumors associated macrophages.24ème édition des journées de l'école doctorale EdNBISE, Mar 2019, Caen, France
Communication dans un congrès
hal-02266827v1
|